CommercialCoverageMedium impact
08.02.27, Tarlatamab-dlle (Imdelltra™) for intravenous use
Independence Blue Cross·Oncology, Pharmacy·Pharmacy
Effective date
Apr 21, 2025
We identified it
Jun 19, 2026
Summary
This is a new pharmacy policy effective 04/21/2025 establishing coverage guidelines for Tarlatamab-dlle (Imdelltra™), an intravenous medication. The billing team must implement this policy immediately to ensure proper coding, prior authorization requirements, and claim submission aligned with this new coverage determination.
Action Required
By 04/21/2025: Billing team must obtain and review the complete policy text from the source URL to identify specific HCPCS/CPT codes for Tarlatamab-dlle administration, prior authorization requirements, and medical necessity criteria. Update billing software with any new codes and prior auth rules. Notify providers and clinical staff of coverage requirements. Contact the payer directly if specific billing codes are not detailed in the policy summary provided. Failure to implement proper coding and prior authorization will result in claim denials.